May 28, 2020 / 7:03 AM / a month ago

BRIEF-Cordenpharma & Moderna Extend Strategic Manufacturing Services Agreement For The Supply Of Lipid Excipients To Be Used In Moderna's Vaccine Mrna-1273

May 28 (Reuters) - CordenPharma:

* CORDENPHARMA & MODERNA EXTEND STRATEGIC MANUFACTURING SERVICES AGREEMENT FOR THE SUPPLY OF LIPID EXCIPIENTS TO BE USED IN MODERNA’S VACCINE (MRNA-1273) AGAINST THE NOVEL CORONAVIRUS SARS-COV-2

* CORDENPHARMA - COS WILL FURTHER EXTEND THEIR SUPPLY RELATIONSHIP BY EXPANDING MANUFACTURING AGREEMENT ORIGINALLY SIGNED IN 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below